IV Daratumumab versus Subcutaneous Daratumumab

IV Daratumumab versus Subcutaneous Daratumumab

obr

7 months
115 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Saad Usmani, MD, Chief, Plasma Cell Disorders Program, Hematologic Malignancies, Levine Cancer Institute/Atrium Health, UNC Chapel Hill School of Medicine, compares intravenous daratumumab versus subcutaneous daratumumab.
Up Next Autoplay